532628 Sigma-AldrichVps34 Inhibitor, VPS34-IN1 - CAS 1383716-33-3 - Calbiochem
A cell-permeable, highly potent, selective, and reversible inhibitor of Vps34 activity (IC₅₀ = 25 nM).
More>> A cell-permeable, highly potent, selective, and reversible inhibitor of Vps34 activity (IC₅₀ = 25 nM). Less<<Sinonimi: 1-(2-(2-Chloropyridin-4-ylamino)-4ʹ-(cyclopropylmethyl)-4,5ʹ-bipyrimidin-2ʹ-ylamino)-2-methylpropan-2-ol, Vacuolar Protein Sorting 34 Inhibitor, PIK3C3 Inhibitor
Prodotti consigliati
Panoramica
Replacement Information |
---|
Tabella delle specifiche principali
CAS # | Empirical Formula |
---|---|
1383716-33-3 | C₂₁H₂₄ClN₇O |
Prezzi e disponibilità
Numero di catalogo | Disponibilità | Confezionamento | Qtà/conf | Prezzo | Quantità | |
---|---|---|---|---|---|---|
5326280001 |
|
Bottiglia di vetro | 5 mg |
|
— |
References | |
---|---|
References | Bago, R., et al. 2014. Biochem. J. 463, 413. |
Product Information | |
---|---|
CAS number | 1383716-33-3 |
Form | White powder |
Hill Formula | C₂₁H₂₄ClN₇O |
Chemical formula | C₂₁H₂₄ClN₇O |
Reversible | Y |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Vps34 |
Primary Target IC<sub>50</sub> | 25 nM using recombinant Vsp34:Vps15 complex |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Numero di catalogo | GTIN |
5326280001 | 04055977281835 |
Documentation
Vps34 Inhibitor, VPS34-IN1 - CAS 1383716-33-3 - Calbiochem MSDS
Titolo |
---|
Riferimenti bibliografici
Panoramica delle referenze |
---|
Bago, R., et al. 2014. Biochem. J. 463, 413. |
Informazioni tecniche
Titolo |
---|
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
White Paper: Further considerations of antibody validation and usage. |